7Baggers
 lona sec filings - leonabio inc 10-k, 10-q, 8-k forms  Stock Titan Sat, 27 Jun 2026 04:07:31 GMT
 athira pharma inc (atha) valuation: pe, pb & fair value analysis  TradingKey Thu, 18 Jun 2026 05:28:14 GMT
 athira pharma inc (atha) institutional confidence  TradingKey Thu, 18 Jun 2026 05:25:33 GMT
 LONA - LeonaBio Inc Stock Price and Quote  Finviz Fri, 29 May 2026 13:45:03 GMT
 leonabio gets $20 price target ahead of june pipeline test  Bez Kabli Thu, 28 May 2026 07:00:00 GMT
 tradingkey  TradingKey Tue, 12 May 2026 09:57:49 GMT
 director at leonabio (lona) granted 56,000 stock options  Stock Titan Fri, 08 May 2026 00:40:18 GMT
 option grant gives leonabio (lona) director 56,000 shares at $9.63  Stock Titan Fri, 08 May 2026 00:39:29 GMT
 natalie holles named leonabio (lona) director in initial form 3  Stock Titan Fri, 08 May 2026 00:38:21 GMT
 leonabio (lona) director peter b. silverman files initial form 3  Stock Titan Fri, 08 May 2026 00:35:22 GMT
 option grant gives leonabio (lona) director 56,000 shares at $9.63  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 natalie holles named leonabio (lona) director in initial form 3  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 director at leonabio (lona) granted 56,000 stock options  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 leonabio (lona) director peter b. silverman files initial form 3  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 leonabio ceo litton sells $27,687 in shares  Investing.com Mon, 20 Apr 2026 07:00:00 GMT
 athira pharma (nasdaq:lona) shares down 6.5% - should you sell?  MarketBeat Wed, 15 Apr 2026 01:18:03 GMT
 athira pharma (nasdaq:lona) shares down 6.5% - should you sell?  MarketBeat Tue, 14 Apr 2026 07:00:00 GMT
 28,000-share stock option grant to leonabio (lona) director  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 leonabio (lona) grants cmo 350,000 options at $9.54  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 leonabio (lona) cfo awarded 300,000 stock options at $9.54  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 leonabio (lona) director awarded options on 28,000 shares at $9.54  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 28,000 stock options granted to leonabio (lona) director kosacz  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 leonabio (lona) ceo awarded 750,000 stock options at $9.54 strike  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 leonabio (lona) awards 300,000 stock options to general counsel  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 top athira pharma (lona) competitors 2026  MarketBeat Sun, 12 Apr 2026 07:19:16 GMT
 cantor fitzgerald reiterates overweight on leonabio stock  Investing.com Tue, 07 Apr 2026 07:00:00 GMT
 athira pharma, inc. (atha) competitors  Meyka Thu, 02 Apr 2026 16:46:00 GMT
 [effect] leonabio, inc. sec filing  Stock Titan Thu, 02 Apr 2026 07:00:00 GMT
 [effect] leonabio, inc. sec filing  Stock Titan Wed, 01 Apr 2026 07:00:00 GMT
 leonabio (atha) clears resale of 5.5m warrant shares for sermonix  Stock Titan Tue, 31 Mar 2026 07:00:00 GMT
 leonabio updates investors on 2025 results and strategy  TipRanks Fri, 27 Mar 2026 02:50:25 GMT
 LeonaBio lines up $90M and a 2027 readout for breast cancer drug  Stock Titan Thu, 26 Mar 2026 07:00:00 GMT
 leonabio updates investors on 2025 results and strategy  TipRanks Thu, 26 Mar 2026 07:00:00 GMT
 seattle inno - athira's woes i zap energy's big raise  The Business Journals Wed, 25 Mar 2026 03:16:09 GMT
 leonabio shareholders approve equity plan and increase in authorized shares  Investing.com UK Fri, 20 Mar 2026 00:00:17 GMT
 published on: 2026-03-20 02:58:44  baoquankhu1.vn Thu, 19 Mar 2026 20:03:44 GMT
 top athira pharma (lona) competitors 2026  MarketBeat Wed, 11 Mar 2026 12:05:31 GMT
 [defr14a] leonabio, inc. revised proxy statement  Stock Titan Wed, 11 Mar 2026 09:17:46 GMT
 spruce street capital - financial details  Crunchbase Wed, 11 Mar 2026 00:19:16 GMT
 [defr14a] leonabio, inc. revised proxy statement  Stock Titan Tue, 10 Mar 2026 07:00:00 GMT
 [defr14a] leonabio, inc. revi...  Stock Titan Tue, 10 Mar 2026 07:00:00 GMT
 leonabio ceo litton sells $27,687 in shares by investing.com  Investing.com India Fri, 06 Mar 2026 08:00:00 GMT
 leonabio ceo litton sells $27,687 in shares  Investing.com Fri, 06 Mar 2026 01:18:44 GMT
 renninger, leonabio cfo, sells $4.9k in lona stock  Investing.com South Africa Fri, 06 Mar 2026 00:57:23 GMT
 leonabio (atha) counsel sells 1,328 shares to cover rsu tax bill  Stock Titan Fri, 06 Mar 2026 00:28:50 GMT
 leonabio (atha) cfo sells shares to cover taxes after rsu vesting  Stock Titan Fri, 06 Mar 2026 00:28:50 GMT
 leonabio (atha) ceo converts 22,254 rsus and sells shares for taxes  Stock Titan Fri, 06 Mar 2026 00:28:50 GMT
 leonabio (lona) cmo covers rsu tax bill with share sale  Stock Titan Fri, 06 Mar 2026 00:02:38 GMT
 leonabio ceo litton sells $27,687 in shares  Investing.com Thu, 05 Mar 2026 08:00:00 GMT
 renninger, leonabio cfo, sells $4.9k in lona stock  Investing.com Thu, 05 Mar 2026 08:00:00 GMT
 leonabio (lona) cso exercises 5,856 rsus and sells shares for taxes  Stock Titan Thu, 05 Mar 2026 08:00:00 GMT
 leonabio (atha) ceo converts 22,254 rsus and sells shares for taxes  Stock Titan Thu, 05 Mar 2026 08:00:00 GMT
 leonabio (atha) counsel sells 1,328 shares to cover rsu tax bill  Stock Titan Thu, 05 Mar 2026 08:00:00 GMT
 leonabio (atha) cfo sells shares to cover taxes after rsu vesting  Stock Titan Thu, 05 Mar 2026 08:00:00 GMT
 leonabio (lona) cmo covers rsu tax bill with share sale  Stock Titan Thu, 05 Mar 2026 08:00:00 GMT
 leonabio ceo litton sells $27,687 in shares by investing.com  Investing.com Canada Thu, 05 Mar 2026 08:00:00 GMT
 leonabio (nasdaq: atha) files to sell 22,254 shares after rsu lapse  Stock Titan Thu, 05 Mar 2026 01:02:12 GMT
 athira pharma (lona) stock forecast and price target 2026 $lona  MarketBeat Wed, 04 Mar 2026 16:36:57 GMT
 leonabio (nasdaq: atha) files to sell 22,254 shares after rsu lapse  Stock Titan Wed, 04 Mar 2026 08:00:00 GMT
 comparing athira pharma (nasdaq:lona) & prime medicine (nasdaq:prme)  Defense World Wed, 04 Mar 2026 07:26:20 GMT
 leonabio (lona) cso exercises 5,856 rsus and sells shares for taxes  Stock Titan Tue, 03 Mar 2026 08:00:00 GMT
 athira pharma (lona) stock forecast and price target 2026 $lona  MarketBeat Tue, 03 Mar 2026 06:16:10 GMT
 athira pharma (lona) 10k form and sec filings 2026 $lona  MarketBeat Tue, 03 Mar 2026 04:43:44 GMT
 cantor fitzgerald initiates leona bio stock with overweight rating by investing.com  Investing.com Australia Fri, 27 Feb 2026 03:25:08 GMT
 cantor fitzgerald initiates leona bio stock with overweight rating  Investing.com Thu, 26 Feb 2026 08:00:00 GMT
 reviewing prime medicine (nasdaq:prme) and athira pharma (nasdaq:lona)  Defense World Thu, 26 Feb 2026 07:33:02 GMT
 atha financials: income statement, balance sheet & cash flow  Stock Titan Mon, 23 Feb 2026 15:51:34 GMT
 leonabio shares rise after mizuho securities upgrade  marketscreener.com Thu, 19 Feb 2026 19:59:13 GMT
 mizuho upgrades leonabio stock rating on breast cancer drug potential by investing.com  Investing.com South Africa Thu, 19 Feb 2026 08:00:00 GMT
 mizuho upgrades leonabio stock rating on breast cancer drug potential  Investing.com Wed, 18 Feb 2026 08:00:00 GMT
 athira pharma (nasdaq:lona) upgraded at wall street zen  Defense World Sat, 14 Feb 2026 07:25:04 GMT
 athira pharma (lona) stock trends and sentiment 2026 $lona  MarketBeat Fri, 13 Feb 2026 01:00:52 GMT
 athira pharma (lona) stock forecast and price target 2026 $lona  MarketBeat Fri, 13 Feb 2026 00:57:57 GMT
 lona news today | why did athira pharma stock go up today?  MarketBeat Fri, 13 Feb 2026 00:57:19 GMT
 lona news today | why did athira pharma stock go down today?  MarketBeat Fri, 13 Feb 2026 00:57:19 GMT
 athira pharma (lona) earnings date and reports 2026 $lona  MarketBeat Fri, 13 Feb 2026 00:54:14 GMT
 athira pharma (lona) stock price, news & analysis $lona  MarketBeat Fri, 13 Feb 2026 00:54:13 GMT
 top athira pharma (lona) competitors 2026  MarketBeat Fri, 13 Feb 2026 00:54:13 GMT
 athira pharma (lona) stock chart and price history 2026 $lona  MarketBeat Fri, 13 Feb 2026 00:27:19 GMT

Athira Pharma, Inc
(NASDAQ:ATHA) 

ATHA stock logo

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in LIFT-AD...

Founded: 2011
CEO: Leen Kawas  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends